View Item 

Show simple item record

Tolerance to Μ-opioid agonists in human neuroblastoma SH-SY5Y cells as determined by changes in guanosine-5′-O-(3-[ 35 S]-thio)triphosphate binding
dc.contributor.authorElliott, Jackieen_US
dc.contributor.authorGuo, Lien_US
dc.contributor.authorTraynor, John R.en_US
dc.date.accessioned2010-06-01T18:30:54Z
dc.date.available2010-06-01T18:30:54Z
dc.date.issued1997-07en_US
dc.identifier.citationElliott, Jackie; Guo, Li; Traynor, John R (1997). "Tolerance to Μ-opioid agonists in human neuroblastoma SH-SY5Y cells as determined by changes in guanosine-5′-O-(3-[ 35 S]-thio)triphosphate binding." British Journal of Pharmacology 121(7): 1422-1428. <http://hdl.handle.net/2027.42/71721>en_US
dc.identifier.issn0007-1188en_US
dc.identifier.issn1476-5381en_US
dc.identifier.urihttps://hdl.handle.net/2027.42/71721
dc.identifier.urihttp://www.ncbi.nlm.nih.gov/sites/entrez?cmd=retrieve&db=pubmed&list_uids=9257923&dopt=citationen_US
dc.format.extent381027 bytes
dc.format.extent3109 bytes
dc.format.mimetypeapplication/pdf
dc.format.mimetypetext/plain
dc.publisherBlackwell Publishing Ltden_US
dc.rights1997 British Pharmacological Societyen_US
dc.subject.otherΜ-Opioid Receptor Agonistsen_US
dc.subject.otherMorphineen_US
dc.subject.otherDAMGOen_US
dc.subject.other[ 35 S]-GTPΓS Bindingen_US
dc.subject.otherToleranceen_US
dc.subject.otherSH-SY5Y Cellsen_US
dc.titleTolerance to Μ-opioid agonists in human neuroblastoma SH-SY5Y cells as determined by changes in guanosine-5′-O-(3-[ 35 S]-thio)triphosphate bindingen_US
dc.typeArticleen_US
dc.subject.hlbsecondlevelPharmacy and Pharmacologyen_US
dc.subject.hlbtoplevelHealth Sciencesen_US
dc.description.peerreviewedPeer Revieweden_US
dc.contributor.affiliationumDepartment of Pharmacology, University of Michigan Medical School, Ann Arbor, Michigan, 48109, U.S.A.en_US
dc.identifier.pmid9257923en_US
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/71721/1/sj.bjp.0701253.pdf
dc.identifier.doi10.1038/sj.bjp.0701253en_US
dc.identifier.sourceBritish Journal of Pharmacologyen_US
dc.identifier.citedreferenceAdams, J. & Holtzman, S.R. ( 1990 ). Tolerance and dependence after continuous morphine infusion from osmotic pumps measured by operant responding in rats. Psychopharmacology, 100, 451 – 458.en_US
dc.identifier.citedreferenceAloyo, V.J. ( 1995 ). Modulation of mu opioid binding by protein kinase inhibitors. Biochem. Pharmacol. 49, 17 – 21.en_US
dc.identifier.citedreferenceCarroll, J.A., Shaw, J.S. & Wickenden, A.D. ( 1988 ). The physiological relevance of low agonist affinity binding at opioid Μ-receptors. Br. J. Pharmacol., 94, 625 – 631.en_US
dc.identifier.citedreferenceCarter, B.D. & Medzihradsky, F. ( 1992 ). Opioid signal transduction in intact and fragmented SH-SY5Y neural cells. J. Neurochem., 58, 1611 – 1619.en_US
dc.identifier.citedreferenceCarter, B.D. & Medzihradsky, F. ( 1993a ). Receptor mechanisms of opioid tolerance in SH-SY5Y human neural cells. Mol. Pharmacol., 43, 465 – 473.en_US
dc.identifier.citedreferenceCarter, B.D. & Medzihradsky, F. ( 1993b ). Go mediates the coupling of Μ opioid receptor adenylyl cyclase in cloned neural cells and brain. Proc. Natl. Acad. Sci. U.S.A., 90, 4062 – 4066.en_US
dc.identifier.citedreferenceCheng, J., Standifer, K.M., Tublin, P.R., Su, W. & Pasternak, G.W. ( 1995 ). Demonstration of Κ 3 opioid receptors in the SH-SY5Y human neuroblastoma cell line. J. Neurochem., 65, 170 – 175.en_US
dc.identifier.citedreferenceCheng, Y.C. & Prussoff, W.H. ( 1973 ). Relationship between the inhibition constant (Ki) and the concentration of inhibitor which causes 50 per cent inhibition (150) of an enzymic reaction. Biochem. Pharmacol., 22, 3099 – 3108.en_US
dc.identifier.citedreferenceChidiac, P., Nouet, S. & Bouvier, M. ( 1996 ). Agonist-induced modulation of inverse agonist efficacy at the Β2-adrenergic receptor. Mol. Pharmacol., 50, 662 – 669.en_US
dc.identifier.citedreferenceChilders, S.R. ( 1991 ). Opioid-receptor coupled 2nd messenger systems. Life Sci., 48, 1991 – 2002.en_US
dc.identifier.citedreferenceChristie, M.J., Williams, J.T. & North, R.A. ( 1987 ). Cellular mechanisms of opioid tolerance: studies in single brain neurons. Mol. Pharmacol., 32, 633 – 638.en_US
dc.identifier.citedreferenceElliott, J., Lambert, D.G., Smart, D. & Traynor, J.R. ( 1994 ). Characterisation of Μ-opioid receptors on SH-SY5Y cells using naloxonazine and Β-funaltrexamine. Eur. J. Pharmacol. Mol. Pharmacol., 268, 447 – 450.en_US
dc.identifier.citedreferenceElliott, J. & Traynor, J.R. ( 1994 ). [ 35 S]GTPΓS binding in SH-SY5Y human neuroblastoma cells as a model for the study of opioid tolerance. Regul. Peptides, 54, 91 – 92.en_US
dc.identifier.citedreferenceHidaka, H., Inagaki, M., Kawamoto, S. & Sasaki, Y. ( 1984 ). Isoquinolinesulfonamides, novel and potent inhibitors of cyclic nucleotide dependent kinase and protein kinase C. Biochemistry, 23, 5036 – 5041.en_US
dc.identifier.citedreferenceKazmi, S.M. & Mishra, R.K. ( 1987 ). Comparative pharmacological properties and functional coupling of Μ and Δ opioid receptor sites in human neuroblastoma SH-SY5Y cells. Mol. Pharmacol., 32, 109 – 118.en_US
dc.identifier.citedreferenceKennedy, C. & Henderson, G. ( 1991 ). Μ-Opioid receptor inhibition of calcium current: development of homologous tolerance in single SH-SY5Y cells after chronic exposure to morphine in vitro. Mol. Pharmacol., 40, 1000 – 1005.en_US
dc.identifier.citedreferenceKenakin, T. ( 1993 ). Pharmacologic Analysis of Drug-Receptor Interactions. 2nd edition, pp 249 – 277. New York: Raven Press.en_US
dc.identifier.citedreferenceLameh, J., Eiger, S. & Sadee, W. ( 1992 ). Interaction among Μ-opioid receptors and Α 2 -adrenoceptors on SH-SY5Y human neuroblastoma cells. Eur. J. Pharmacol., 227, 19 – 24.en_US
dc.identifier.citedreferenceLaugwitz, K.-H., Offermanns, S., Spicher, K. & Schultz, G. ( 1993 ). Μ and Δ opioid receptors differentially couple to G protein subtypes in membranes of human neuroblastoma SH-SY5Y cells. Neuron, 10, 233 – 242.en_US
dc.identifier.citedreferenceLowry, O.H., Rosenberg, N.G., Farr, A.L. & Randall, R.J. ( 1951 ). Protein measurement with the Folin phenol reagent. J. Biol. Chem., 139, 265 – 275.en_US
dc.identifier.citedreferenceMiller, S.W., Haske, T.N., Raby, C.A. & Levine, H. ( 1993 ). Inhibition of Β 2 adrenergic receptor desensitization. Soc. Neurosci Abs., 19, 181 – 5.en_US
dc.identifier.citedreferenceMunson, P.J. & Rodbard, D. ( 1980 ). LIGAND: a versatile computerised approach for characterisation of ligand-binding systems. Anal. Biochem., 107, 220 – 239.en_US
dc.identifier.citedreferenceNestler, E.J. ( 1993 ). Cellular responses to chronic treatment with drugs of abuse. Critical Rev. Neurobiol., 7, 23 – 39.en_US
dc.identifier.citedreferencePak, Y., Kouvelas, A., Scheideler, M.A., Rasmussen, J., O'Dowd, B.F. & George, S.R. ( 1996 ). Agonist-induced functional desensitization of the Μ- opioid receptor is mediated by loss of membrane receptors rather than uncoupling from G protein. Mol. Pharmacol. 50, 1214 – 1222.en_US
dc.identifier.citedreferencePei, G., Keiffer, B.L., Lefkowitz, R.J. & Freedman, N.J. ( 1995 ). Agonist-dependent phosphorylation of the mouse Δ-opioid receptor: involvement of G-protein-coupled receptor kinases but not protein kinase C. Mol. Pharmacol., 48, 173 – 177.en_US
dc.identifier.citedreferencePrather, P.L., Tsai, A.W., & Law, P.Y. ( 1994 ). Mu and delta opioid receptor desensitization in undifferentiated human neuroblastoma cell SH-SY5Y cells. J. Pharmacol. Exp. Ther., 270, 177 – 184.en_US
dc.identifier.citedreferencePuttfarcken, P.S., Werling, L.L. & Cox, B.M. ( 1988 ). Effects of chronic morphine exposure on opioid inhibition of adenylyl cyclase in 7315c cell membranes: a useful model for the study of tolerance at Μ opioid receptors. Mol. Pharmacol., 33, 520 – 527.en_US
dc.identifier.citedreferenceRaynor, K., Kong, H., Hines, J., Kong, G., Benovic, J., Yasuda, K., Bell, G. & Reisine, T. ( 1994 ). Molecular mechanisms of agonist-induced desensitization of the cloned mouse kappa opioid receptor. J. Pharmacol. Exp. Ther., 270, 1381 – 1386.en_US
dc.identifier.citedreferenceSchiller, P.W., Nguyen, T.M.D., Weltowska, G., Wilkes, B.C., Marsden, B.C., Lemieux, C. & Chung, N.N. ( 1992 ). Differential stereochemical requirements of Μ versus Δ opioid receptors for ligand binding and signal transduction: development of a class of potent and highly Δ-selective peptide antagonists. Proc. Natl. Acad. Sci. U.S.A., 89, 11871 – 11875.en_US
dc.identifier.citedreferenceTraynor, J.R. ( 1994 ). Opioid receptors and their subtypes: Focus on peripheral isolated tissue preparations. Neurochem. Int., 24, 427 – 432.en_US
dc.identifier.citedreferenceTraynor, J.R. & Nahorski, S.R. ( 1995 ). Modulation by Μ-opioid agonists of guanosine-5′-O-(3-[ 35 S]thio)triphosphate binding to membranes from human neuroblastoma SH-SY5Y cells. Mol. Pharmacol., 47, 848 – 854.en_US
dc.identifier.citedreferenceTraynor, J.R. & Wood, M.S. ( 1989 ). [ 3 H]Diprenorphine binding to kappa-sites in guinea-pig and rat brain: evidence for apparent heterogeneity. J. Neurochem., 53, 173 – 178.en_US
dc.identifier.citedreferenceUeda, H., Miyamea, T., Hayashi, C., Watanabe, S., Fukushima, N., Sasaki, Y., Iwamura, T. & Misu, Y. ( 1995 ). Protein kinase C involvement in homologous desensitization of the Δ-opioid receptor coupled to G il -phospholipase C activation in xenopus oocytes. J. Neurosci., 15, 7485 – 7499.en_US
dc.identifier.citedreferenceUhl, G.R., Childers, S. & Pasternak, G.W. ( 1993 ). An opiate-receptor gene family reunion. Trends Pharmacol. Sci., 17, 89 – 93.en_US
dc.identifier.citedreferenceVan Vliet, B., Van Rijswijk, A.L.C.T., Wardeh, G., Mulder, A.H. & Schoffelmeer, A.N.M. ( 1993 ). Adaptive changes in the number of Gs- and Gi-proteins underlie adenylyl cyclase sensitization in morphine-treated rat striatal neurons. Eur. J. Pharmacol., 245, 23 – 29.en_US
dc.identifier.citedreferenceWang, Z., Bilsky, E.J., Porreca, F. & Sadee, W. ( 1994 ). Constitutive Μ opioid receptor activation as a regulatory mechanisms underlying narcotic tolerance and dependence. Life Sci., 54, 339 – 350.en_US
dc.identifier.citedreferenceYu, V.C. & Sadee, W. ( 1988 ). Efficacy and tolerance of narcotic analgesics at the mu opioid receptor in differentiated human neuroblastoma cells. J. Pharmacol. Exp. Ther., 245, 350 – 355.en_US
dc.identifier.citedreferenceZadina, J.E., Chang, S.L., Ge, L.-J. & Kastin, A.J. ( 1993 ). Mu opiate receptor down-regulation by morphine and up-regulation by naloxone in SH-SY5Y human neuroblastoma cells. J. Pharmacol. Exp. Ther., 265, 254 – 262.en_US
dc.identifier.citedreferenceZadina, J.E., Harrison, L.M., Ge, L.-J., Kastin, A.J. & Chang, S.L. ( 1994 ). Differential regulation of mu and delta opiate receptors by morphine, selective agonists and antagonists and differentiating agents in SH-SY5Y human neuroblastoma cells. J. Pharmacol. Exp. Ther., 270, 1086 – 1096.en_US
dc.owningcollnameInterdisciplinary and Peer-Reviewed


Files in this item

Name:
sj.bjp.0701253.pdf
Size:
372.0KB
Format:
PDF
View/Open

Show simple item record

Remediation of Harmful Language

The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.

Accessibility

If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.